Skip to content
PEPTIDE READER

Weight, blood sugar & heart

Peptides for blood pressure

Peptides that lower blood pressure: one entry qualifies, and it is on this page because a regulator tested the claim and the claim failed.

The evidence mix

The one peptide on this page, by how well it has been tested.

  1. Approved medicinenone on this page
  2. Still being tested in peoplenone on this page
  3. Tested in people, but barely1 peptide
  4. Only tested on animalsnone on this page
  5. No real evidence at allnone on this page
How we grade evidence

Two short peptides left over from fermenting milk are sold in functional foods and supplements for blood pressure. The European Food Safety Authority assessed that claim and concluded that a cause-and-effect relationship had not been established, and the European Commission refused it. Around thirty randomised trials do exist, but most were funded by companies selling the product, and what they measure is a blood-pressure reading over a few weeks rather than whether anyone went on to have fewer heart attacks or strokes. Trials run in Japan report larger effects than trials run in Europe, which is a fact about the evidence rather than about the peptides. One compound is still a page, and this is what a supplement claim looks like after someone official has checked it.

The one peptide on this page

Filter these in the full register

Tested in people, but barely

Human studies exist, but they are small, short, uncontrolled, paid for by the seller, or they measure something easy to measure instead of something that matters.

1 peptide

  1. Evidence level 3 of 5: Tested in people, but barely

    Lactotripeptides (IPP and VPP)

    IPP · VPP

    Sold in fermented milk drinks and supplements for blood pressure.

    Europe's food safety authority assessed the blood pressure claim twice and concluded a cause-and-effect relationship had not been established.

    Sold as: Supplement